The Mount Sinai Center for Vaccine Research and Pandemic Preparedness has conducted research on a variety of vaccines. Learn more about our renowned research below.
- Mapping SARS-CoV-2 antigenic relationships and serological responses
- Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
- Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
- The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
- Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
- PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2
- Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer
- Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain
- Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies
- Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients
- Defining the risk of SARS-CoV-2 variants on immune protection
- The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
- Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
- Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma
- Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus